This guide provides clinical and programmatic advice to program managers and frontline health workers on the bi-directional screening of TB and diabetes mellitus. The resource also includes information on the management and treatment of patients with TB and diabetes mellitus.
This video from World Hepatitis Alliances highlights youth voices and a discussion on viral hepatitis and HIV.
This webpage discusses how viral hepatitis disproportionately impacts Hispanic/Latinx communities. In 2018, Hispanic/Latinx individuals were 1.4 times more likely to die from Hepatitis C than non-Hispanic whites, with significant barriers such as language, access to care, and high-risk behaviors contributing to these disparities. Despite the availability of effective treatments, Hispanic/Latinx patients face significant treatment gaps. Social determinants of health, such as lower insurance coverage and limited access to quality care, exacerbate these issues.
In this webinar, the Hepatitis B Foundation is pleased to share the news that the World Health Organization (WHO) has released new “Guidelines for the prevention, diagnosis, care and treatment for people with chronic hepatitis B infection. This webinar helps convey the new guidelines.
This webinar session features speakers Anika Martin from Hep Free Hawaii and Monique Benvenutti from Hepatitis B Foundation, exploring best practices for social media engagement and sharing impactful strategies, demonstrating how one person can turn social media into a powerful team effort for creating awareness about hepatitis B.
In this webinar, Dr. Melodie Weller of University of Utah Health System discusses the epidemiology and screening patterns for Hepatitis Delta Virus in Utah over a 22-year period.
On Thursday 7 March, WHA hosted a panel discussion ahead of International Women’s Day, to explore the unique perspectives of women living with hepatitis. It also celebrated the women that are driving the hepatitis response and supporting other women living with hepatitis.
This infographic from HepVu illustrates hepatitis C treatment restrictions in 2024 and how many states have other requirements that reduce access to hepatitis C care.
The aim of this legal research is to compile enacted state laws and regulations regarding reporting requirements for negative HIV and Hepatitis C test results. The research includes all 50 states as well as the District of Columbia and only covers enacted laws and regulations – excluding proposed bills, sub-regulatory guidance, and case law. Reporting requirements for a specific jurisdiction may vary between health care providers and clinical laboratories. Data displayed within this map excludes provisions specific to prenatal/postnatal testing and exposed newborns – infants.
Tens of thousands of new cases of viral hepatitis occur every year in the United States. Viral hepatitis is a serious public health threat that kills thousands of Americans annually and is a leading cause of liver cancer. Hepatitis A and hepatitis B are vaccine-preventable and hepatitis C can be cured. The Viral Hepatitis Surveillance Report — United States, 2022 presents information from the ongoing, systematic collection, analysis, and interpretation of viral hepatitis-related data.
